Printed peptide arrays identify prognostic TNC serumantibodies in glioblastoma patients

Liquid biopsies come of age offering unexploited potential to monitor and react to tumor evolution. We developed a cost-effective assay to non-invasively determine the immune status of glioblastoma (GBM) patients. Employing newly developed printed peptide microarrays we assessed the B-cell response...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Mock, Andreas, Warta, Rolf, Geisenberger, Christoph, Bischoff, Ralf, Schulte, Alexander, Lamszus, Katrin, Stadler, Volker, Felgenhauer, Thomas, Schichor, Christian, Schwartz, Christoph, Matschke, Jakob, Jungk, Christine, Ahmadi, Rezvan, Sahm, Felix, Capper, David, Glass, Rainer, Tonn, Jörg-Christian, Westphal, Manfred, von Deimling, Andreas, Unterberg, Andreas, Bermejo, Justo Lorenzo, Herold-Mende, Christel
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2015
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4537035/
https://ncbi.nlm.nih.gov/pubmed/25944688
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items